Biotech innovation is often limited by strict privacy regulations and fragmented data access.
ECLIPTICA® generates realistic synthetic patient data, enabling research and AI development while maintaining full compliance.
Synthetic data enhances PK/PD modelling by simulating patient responses, optimizing dose selection, supporting real-world evidence generation, and predicting final clinical trial outcomes from interim study data.
Produce high-quality synthetic imaging datasets such as MRI and CT scans. These datasets enable diagnostic AI systems to be trained without requiring real patient data.
Create virtual patient cohorts to simulate clinical trials. This reduces costs, accelerates timelines, and improves the reliability of research outcomes.
Expand datasets for rare conditions with limited real-world data. This allows researchers to build more effective models and improve understanding of underrepresented diseases.